Instrument Inactif

Communiqués LMF ACQU

Actions

LMAO

US5020151008

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities	28/10/22	AQ
LMF ACQUISITION OPPORTUNITIES INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	27/10/22	AQ
LMF ACQUISITION OPPORTUNITIES INC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	19/10/22	AQ
LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.	19/10/22	AQ
LMF ACQUISITION OPPORTUNITIES INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	17/10/22	AQ
LMF ACQUISITION OPPORTUNITIES INC : Other Events, Financial Statements and Exhibits (form 8-K)	28/09/22	AQ
LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination	28/09/22	AQ
SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development	19/09/22	GL
SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development	19/09/22	GL
LMF ACQUISITION OPPORTUNITIES INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	24/08/22	AQ
LMF ACQUISITION OPPORTUNITIES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/08/22	AQ
SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD	01/08/22	GL
SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD	01/08/22	AQ
LMF Acquisition Opportunities : Announces Extension of Deadline to Complete Business Combination - Form 8-K	01/08/22	PU
LMF ACQUISITION OPPORTUNITIES INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	01/08/22	AQ
LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination	30/07/22	AQ
LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination	30/07/22	GL
SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury	20/07/22	GL
SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury	20/07/22	AQ
SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms	07/06/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués LMF ACQU

Actions

LMAO

US5020151008

Communiqués

Filtres